Vogli-Rapid M 0.3mg/1mg/500mg Tablet SR

Aperçu du produit

About Vogli-Rapid M

Vogli-Rapid M is a medication containing the active ingredient Voglibose, classified as Alpha-glucosidase inhibitor. Voglibose is an alpha-glucosidase inhibitor used for lowering postprandial blood glucose levels in people with diabetes mellitus. Voglibose is a research product of Takeda Pharmaceutical Company, Japan's largest pharmaceutical company.

Key Benefits & Uses

• Used for: Voglibose is an alpha-glucosidase inhibitor used for lowering postprandial blood glucose levels in people with diabetes mellitus
• Used for: Voglibose is a research product of Takeda Pharmaceutical Company, Japan's largest pharmaceutical company
• Use only as directed on the product label or by a healthcare professional.

Active Ingredient & Action

Voglibose, the active ingredient in Vogli-Rapid M, belongs to the Alpha-glucosidase inhibitor class. Its clinical use follows the authorised labelling for Voglibose-containing medicines. Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking Vogli-Rapid M. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use Vogli-Rapid M for extended periods without medical advice.